Drug intelligence / Profile preview

Xiaozheng Pill

Development stage: Unknown
Lead developer: Lei Yun Shang
Administration: Oral

Overview

Xiaozheng Pill (消癥丸) is a Traditional Chinese Medicine (TCM) developed and manufactured by Lei Yun Shang. It is formulated to activate blood circulation, resolve blood stasis, and soften hard masses to dissipate them. Clinically, it is primarily indicated for the treatment of gynecological conditions associated with Qi stagnation and blood stasis, including uterine fibroids (leiomyoma), ovarian cysts, and hyperplasia of mammary glands (breast hyperplasia). The formulation typically consists of multiple herbal ingredients such as *Sparganium stoloniferum* (Sanleng), *Curcuma zedoaria* (Ezhu), and *Prunus persica* (Taoren), which are traditionally recognized for their anti-proliferative and stasis-resolving properties. It is an approved pharmaceutical product in China.

Brand names: Xiaozheng Pill
Other names: Xiaozheng Wan消癥丸

Targets

ERBB2 (Erb-b2 receptor tyrosine kinase 2)IL-6 (Interleukin 6)VEGFA (Vascular endothelial growth factor A)JNK (Mitogen-activated protein kinase kinase kinase family)ESR1 (ERα)EGFR T790M (Epidermal growth factor receptor T790M mutant)CASP3 (Caspase-3)

Beyond the preview

Go deeper on Xiaozheng Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaozheng Pill.

Explore the full profile